Edition:
United States

Tandem Diabetes Care Inc (TNDM.OQ)

TNDM.OQ on NASDAQ Stock Exchange Global Market

33.62USD
12:50pm EDT
Change (% chg)

$-0.29 (-0.86%)
Prev Close
$33.91
Open
$33.91
Day's High
$34.85
Day's Low
$33.17
Volume
382,801
Avg. Vol
599,873
52-wk High
$35.03
52-wk Low
$2.14

Chart for

About

Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System... (more)

Overall

Beta: 0.01
Market Cap(Mil.): $1,872.62
Shares Outstanding(Mil.): 56.69
Dividend: --
Yield (%): --

Financials

  TNDM.OQ Industry Sector
P/E (TTM): -- 37.48 30.17
EPS (TTM): -12.84 -- --
ROI: -186.79 14.29 12.67
ROE: -4,429.02 17.46 14.86

BRIEF-Tandem Diabetes Care Receives CE Mark for t:slim X2 Insulin Pump

* TANDEM DIABETES CARE-ANNOUNCED RECEIPT OF CE MARK APPROVAL FOR T:SLIM X2 INSULIN PUMP WITH DEXCOM G5® MOBILE CONTINUOUS GLUCOSE MONITORING INTEGRATION

Apr 30 2018

BRIEF-Tandem Diabetes Care Files For Mixed Shelf Of Up To $100 Mln

* TANDEM DIABETES CARE INC FILES FOR MIXED SHELF OF UP TO $100 MILLION - SEC FILING Source : https://bit.ly/2JtPqwk Further company coverage: (Reuters.Briefs@thomsonreuters.com)

Apr 26 2018

BRIEF-Tandem Diabetes Care Reports Qtrly Net Loss Per Share, Basic And Diluted Of $1.82

* TANDEM DIABETES CARE REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

Apr 26 2018

BRIEF-Tandem Diabetes Care Announces Insulin Pump Products Distribution Agreements In Australia And New Zealand

* TANDEM DIABETES CARE SAYS ANNOUNCES AGREEMENTS FOR DISTRIBUTION OF INSULIN PUMP PRODUCTS IN AUSTRALIA AND NEW ZEALAND Source text for Eikon: Further company coverage:

Apr 23 2018

BRIEF-Tandem Diabetes Care Q1 Sales $27 Mln Vs I/B/E/S View $25 Mln

* TANDEM DIABETES CARE ANNOUNCES PRELIMINARY FIRST QUARTER 2018 RESULTS

Apr 10 2018

BRIEF-Tandem Diabetes Care And Movi SpA Announce Agreement For Distribution Of Insulin Pump Products In Italy

* TANDEM DIABETES CARE AND MOVI SPA ANNOUNCE AGREEMENT FOR DISTRIBUTION OF INSULIN PUMP PRODUCTS IN ITALY

Apr 09 2018

BRIEF-Tandem Diabetes Care Q4 Sales $40.3 Million

* ‍SALES FOR Q1 OF 2018 ARE ESTIMATED TO BE 18 PERCENT - 19 PERCENT OF ANNUAL SALES​

Mar 01 2018

BRIEF-Tandem Diabetes Care Applies For Health Canada Medical Device License

* TANDEM DIABETES CARE APPLIES FOR HEALTH CANADA MEDICAL DEVICE LICENSE

Feb 20 2018

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $133.91 +1.43
Roche Holding Ltd. (ROG.S) CHF239.95 +0.75
Roche Holding Ltd. (RO.S) CHF243.20 +0.20
Insulet Corporation (PODD.OQ) $87.47 -0.56

Earnings vs. Estimates